Latent Labs
Healthcare AI
Drug discovery / generative protein design
Series A
Latent Labs is a frontier AI lab building generative foundation models for biology, with a focus on programmable protein design for healthcare and sustainability. The company says its platform helps biotech and pharmaceutical partners create new antibodies, optimize enzymes, and advance genetic engineering, and it launched Latent-X for generating lab-functional protein binders.
Company Details
- Website
- latentlabs.com
- Headquarters
- London, UK; San Francisco, CA, USA
- Founded
- 2023
- Funding
- $50M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring